Sysorex announced that it has elected William B. Stilley, III as chair of the board’s audit committee. The company also expanded the size of its board to five directors and established its audit committee. Stilley is the Chief Executive Officer of Adial Pharmaceuticals, Inc. Prior to joining Adial, he was the Vice President, Business Development & Strategic Projects at Clinical Data, Inc. Stilley also served as the Chief Operating Officer and Chief Financial Officer of Adenosine Therapeutics LLC. Prior to his corporate career, Stilley was Captain in the U.S. Marine Corps. He serves on the board of Avalon Globocare Corp. and the Virginia BIO board of advisors.